Hirudin protects from leukocyte/endothelial cell interaction induced by extracorporeal circulation

Thorac Cardiovasc Surg. 2001 Jun;49(3):157-61. doi: 10.1055/s-2001-14293.

Abstract

Background: The clinical complications of Extracorporeal Circulation (ECC) have been linked to disturbances in the microcirculation. In order to prevent these deleterious effects, a biodegradeable agent to coat the extracorporeal circuit was tested.

Methods: Intravital fluorescence microscopy was used on the hamster skinfold chamber model in permanently instrumented, awake animals. ECC was introduced via a micro-roller-pump and a silicon tube shunted between the carotid artery and the jugular vein. The ECC-tube system was coated with PEG-Hirudin-Iloprost, two additional groups received either Iloprost i.v. (0.8 mg/kg/h) or Hirudin i.v. (1 mg/kg b.w.).

Results: ECC for 20 minutes resulted in an increase in rolling and adherent leukocytes in postcapillary venules (Roller 9 to 36 [%]; Sticker 24 to 330 [n/mm2]). Use of the coated tube system reduced L/E cell interaction (Roller 9 to 24* [%], Sticker 28 to 194* [n/mm2]; *p<0.05), whereas Hirudin i.v. nearly abolished it.

Conclusions: The protective effects of the coating and of Hirudin i.v are probably a result of an attenuated activation of the coagulation-fibrinolytic system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antithrombins / pharmacology*
  • Arterioles / drug effects
  • Cell Adhesion / drug effects
  • Cell Communication / drug effects
  • Circadian Rhythm / drug effects
  • Cricetinae
  • Disease Models, Animal
  • Electrocardiography
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiology
  • Extracorporeal Circulation / adverse effects*
  • Hemodynamics / drug effects
  • Hirudins / pharmacology*
  • Leukocytes / drug effects*
  • Leukocytes / physiology
  • Mesocricetus
  • Microcirculation / drug effects
  • Muscle, Smooth, Vascular / blood supply
  • Time Factors
  • Venules / drug effects

Substances

  • Antithrombins
  • Hirudins